KTTA Pasithea Therapeutics reports steep Q4 2025 EPS miss far below analyst estimates even as stock edges higher CTEV Claritev shares gain nearly 5 percent despite wider than expected Q4 2025 per share losses iShares MSCI China ETF MCHI Positioned for Upside Amid Resilient Chinese Growth and Middle East Energy Shock Resilience Kevin Warsh Fed Chair Nomination Monetary Policy and Central Bank Communication Analysis Invesco VVR Macro Impact SpaceXs Potential SP Sector Classification A Multifaceted Challenge Fed Dissenters Push Back Against RateCut Signal Citing Policy Uncertainty NASA Selects Blue Origin for First Uncrewed Lunar Mission in 20 Billion Moon Base Plan SpaceX Scrubs Starship V3 Test Flight Targets Friday Retry After 15 Billion Program Spend SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms APEC Meeting Highlights Persistent USChina Trade Divergence After TrumpXi Summit Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model